MINUTES
About Minutes
Back to latest

HealthUS FDA approves Revolution Medicines targeted drug for metastatic pancreatic cancer

The US Food and Drug Administration has approved a targeted drug from Revolution Medicines for adults with metastatic pancreatic cancer who have received prior treatment or cannot undergo combination chemotherapy.

Revolution MedicinesFDApancreatic cancer

CCNN★★★☆☆2026-08-26 16:59Original

US FDA approves Revolution Medicines targeted drug for metastatic pancreatic cancer
Health